View Single Post
Old 07-03-2010, 09:06 PM
bluedahlia's Avatar
bluedahlia bluedahlia is offline
Member
 
Join Date: Dec 2006
Posts: 419
15 yr Member
bluedahlia bluedahlia is offline
Member
bluedahlia's Avatar
 
Join Date: Dec 2006
Posts: 419
15 yr Member
Default

Quote:
Originally Posted by alongcamejones View Post
Remember Thalidimide? The Researcher knew then had to prove it? It took time. Its only a matter of time IHO until how oral L Dopa meds work gets fully understood. But whos going to fund this. Big Pharm? Why would they its one of their cash cows. So it takes individual people to join the dots, compile the evidence. If you think Big Pharm do lots of R&D read an insiders book

Im responding so that myths dont perpetuate but u have to do your own research.

This is from a PhD study going on

Background: Levodopa (L-DOPA) is the most widely used and effective treatment for Parkinson’s disease (PD). Many in vitro studies however have shown that L-DOPA is toxic to dopaminergic neurones and have raised concerns that L-DOPA could cause neurodegeneration and accelerate the progression of PD. Despite extensive research over the last three decades the toxicity of L-DOPA has never been completely understood
So what do you suggest we, who have been hoodwinked into taking this drug, do. Find a tall bridge somewhere?

I'm a skeptic when it comes to pharma, but you offer no solutions, just arguments.
bluedahlia is offline   Reply With QuoteReply With Quote